Venatorx Pharmaceuticals, Inc. — Form D

Venatorx Pharmaceuticals, Inc. of MALVERN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2013-12-04. The offering totals $4.0M, of which $3.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (20)

NameRoleLocation
Daniel C PevearDirectorMalvern, PA
Luigi J XerriDirectorMalvern, PA
SHELLEY J CHUDirectorSAN DIEGO, CA
Timothy J HainesDirectorMalvern, PA
Tomas C HeymanDirectorMalvern, PA
Christopher J BurnsDirectorMalvern, PA
Christopher J BurnsExecutive OfficerMalvern, PA
Daniel C PevearExecutive OfficerMalvern, PA
Anthony J MeehanExecutive OfficerMalvern, PA
Sergei J PetukhovDirectorMalvern, PA
Martin J HeideckerDirectorMalvern, PA
Ezra J FelkerExecutive OfficerMalvern, PA
Michael C DiemDirectorMalvern, PA
Timothy J HenkelExecutive OfficerMalvern, PA
Michael J DiemDirectorMalvern, PA
Vincent J MilanoDirectorMalvern, PA
Carlo J RizzutoDirectorMalvern, PA
Tim J HenkelExecutive OfficerMalvern, PA
Luigi J XerriExecutive OfficerMalvern, PA
James J MurphyExecutive OfficerMalvern, PA

Other filings by this issuer (7)

FiledFormOfferingSold
2023-07-13D/A$48.2M$35.0M
2023-02-27D$16.4M$15.0M
2022-12-22D/A$24.7M$24.7M
2022-09-02D$24.5M$12.7M
2022-04-04D$60.0M$34.0M
2018-11-05D/A$47.1M$27.1M
2017-07-25D$42.0M$21.9M

More